Loading…
Soluble CD14 Subtype in Peripheral Blood is a Biomarker for Early Diagnosis of Sepsis
Abstract Objective To study the value of serum soluble CD14 subtype (sCD14-ST) in early diagnosis of sepsis. Methods Seventy-two patients were diagnosed with systemic inflammatory response syndrome, sepsis, or septic shock. Peripheral blood was collected at 0, 12, 24, and 48 hours after admission to...
Saved in:
Published in: | Laboratory medicine 2020-11, Vol.51 (6), p.614-619 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Abstract
Objective
To study the value of serum soluble CD14 subtype (sCD14-ST) in early diagnosis of sepsis.
Methods
Seventy-two patients were diagnosed with systemic inflammatory response syndrome, sepsis, or septic shock. Peripheral blood was collected at 0, 12, 24, and 48 hours after admission to the hospital. Levels of sCD14-ST, procalcitonin (PCT), hypersensitive C-reactive protein (CRP), and white blood cells (WBC) were determined.
Results
Levels of sCD14-ST in the patients with septic shock were higher than those in the other patients (P < .01) and peaked at 48 h. PCT and CRP levels were similar in the patients at admission but increased by 5 times to 10 times in the next 48 h, especially in the patients with septic shock. WBC levels remained high and did not change dramatically. Receiver operating characteristic analysis revealed that the area under the curve, sensitivity, and specificity values of sCD14-ST to diagnose sepsis were much higher than those of the other markers.
Conclusion
Compared with PCT, CRP, and WBC, sCD14-ST is a better biomarker for the early diagnosis of sepsis. |
---|---|
ISSN: | 0007-5027 1943-7730 |
DOI: | 10.1093/labmed/lmaa015 |